WHO ICTRP trial
Prospective, Multi-Center and Single-Arm Evaluation of the Safety and Efficacy…
ChiCTR1900026696 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1900026696 |
|---|---|
| Public title | Prospective, Multi-Center and Single-Arm Evaluation of the Safety and Efficacy of the In-Situ Fenestration System for the Preservation of the Supra-Arch Artery in the TEVAR for Aortic Arch Pathologies |
| Scientific title | Prospective, Multi-Center and Single-Arm Evaluation of the Safety and Efficacy of the In-Situ Fenestration System for the Preservation of the Supra-Arch Artery in the TEVAR for Aortic Arch Pathologies |
| Primary sponsor | Zhongshan Hospital Fudan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Aortic arch pathologies |
| Interventions | trial group:In-situ fenestration in TEVAR |
| Registration date | Oct 19, 2019 |
| Target size | trial group:65 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: